Prana Biotechnology Limited (PBT.AX)
-ASX 0.24 
0.01(2.04%) 1:00AM EDT
| Prev Close: | 0.25 |
|---|
| Open: | 0.24 |
|---|
| Bid: | 0.24 |
|---|
| Ask: | 0.24 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.24 - 0.25 |
|---|
| 52wk Range: | 0.14 - 0.31 |
|---|
| Volume: | 361,891 |
|---|
| Avg Vol (3m): | 387,558 |
|---|
| Market Cap: | 81.77M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in AUD.
Headlines
- Prana Announces Share Purchase Plan Closedat Reuters(Sun, May 5)
- Prana Announces Share Purchase Plan ClosedMarketwired(Fri, May 3)
- Prana Announces $5.8 Million R&D RefundMarketwired(Thu, Apr 4)
- Prana Provides Clinical Trials Safety and Progress UpdateMarketwired(Wed, Apr 3)
- Prana Announces Successful A$7 million Capital Raisingat Reuters(Wed, Mar 27)
- Prana Announces Successful A$7 Million Capital RaisingMarketwired(Wed, Mar 27)
- Parkinson’s Patients May Be Harmed by Novel Treatmentat Bloomberg(Thu, Mar 21)
- Prana Details Data Showing That PBT2 Reduces Cognitive Impairment Caused by Tau Protein AccumulationMarketwired(Fri, Mar 8)
- Alzheimer’s Seen on Scans Decades Before Dementia, Study Showsat Bloomberg(Thu, Mar 7)
- Prana's PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cells.Marketwired(Wed, Mar 6)
- Prana's PBT434 Inhibits Accumulation of Parkinson's Protein and Subsequent Death of Brain Cellsat Reuters(Tue, Mar 5)
- Prana Announces That PBT2 Reduces Cognitive Impairment Caused by Tau Protein AccumulationMarketwired(Mon, Mar 4)
- Prana to Present at Cowen & Company Health Care Conference on March 4th in Boston, MAMarketwired(Mon, Feb 25)
- Prana Announces New York Academy of Sciences Symposium eBriefing Available Onlineat Reuters(Tue, Jan 29)
- Prana Announces That New York Academy of Sciences eBriefing Is Available OnlineMarketwired(Tue, Jan 29)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 21.08 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Prana Biotechnology Limited engages in the research and development of therapeutic drugs for the treatment of neurological disorders in Australia. The company primarily focuses on the Alzheimers, Parkinsons, and Huntingtons disea...
View More